Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guanxinshutong Capsules
- Development stage
- Unknown
- Lead developer
- Shanxi Buchang Pharmaceutical
- Administration
- Oral
01
Overview
Guanxinshutong Capsules is a Traditional Chinese Medicine (TCM) product developed by Shanxi Buchang Pharmaceutical. It is primarily indicated for the treatment of cardiovascular and cerebrovascular diseases, including coronary heart disease (CHD), stable angina pectoris, and cerebral infarction caused by blood stasis. The formulation typically includes ingredients such as *Choerospondias axillaris* (Guangzao), *Salvia miltiorrhiza* (Danshen), *Dalbergia odorata* (Jiangxiang), and *Borneolum Syntheticum* (Bingpian). Its pharmacological actions involve improving myocardial blood supply, reducing blood viscosity, inhibiting platelet aggregation, and protecting vascular endothelial cells. It is approved in China and widely used in clinical practice for managing symptoms like chest pain, palpitations, and shortness of breath.
- Brand names
- Guanxinshutong Capsules
- Other names
- Guanxin Shutong CapsuleGuanxin Shutong Jiaonang
02
Targets
IL1B (Interleukin-1 beta)NOS3 (eNOS)PIK3CA (Phosphoinositide 3-kinase alpha)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)IL-6 (Interleukin 6)MAPK3 (Mitogen-activated protein kinase 1)VEGFR2 (Vascular endothelial growth factor receptor 2)
Beyond the preview
Go deeper on Guanxinshutong Capsules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guanxinshutong Capsules.